[November 13, 2012]

Research and Markets: Active Pharmaceutical Ingredients (APIs) Market in Asia Pacific to 2017 - Increasing Penetration in China and India Coupled with Low Cost Manufacturing to Fuel Regional Growth

Research and Markets (http://www.researchandmarkets.com/research/x9tc8t/active) has announced the addition of the "Active Pharmaceutical Ingredients (APIs) Market in Asia Pacific to 2017 - Increasing Penetration in China and India Coupled with Low Cost Manufacturing to Fuel Regional Growth" report to their offering.

Outsourcing in Asia to Shrink Japan's Revenue Share

Pharma's interest in outsourcing, combined with rising industrialization in India and China, will mark a drop in Japan's share of the continent's revenue, says a new report from pharmaceutical industry experts GBI Research.

The latest report* predicts Japan's Active Pharmaceutical Ingredients (API) Asia-Pacific revenue share to drop from a dominant 51% in 2011 to 34% by 2017, while less economically mature markets across the region expand their own.

Japan's API market revenue grew from $9.9 billion in 2006 to $15.6 billion last year, but GBI Research expects this growth o slow substantially in the future, reaching $17.2 billion in 2017, at a modest Compound Annual Growth Rate (CAGR) of just 1.7% from 2011.

By comparison, China's API market revenue will increase from the $6.6 billion posted last year to $17 billion by the end of 2017, representing a CAGR of 17.2% during the same time period. Similarly, the API industry in India is expected to expand in value, from $2 billion in 2011 to $5.2 billion in 2017, at a CAGR of 17.4%.

A major contributor to this disparity in growth is the growing popularity of outsourcing pharmaceutical processes to Contract Manufacturing Organizations (CMO) in developing countries where skilled workforces are readily available and labor costs can be as much as 12 times lower.

The CMO market for the Asia-Pacific region is expected to jump in value in the near future. From combined revenues of $6.6 billion last year, GBI Research forecasts the sector to reach $16.5 billion by just 2017 at a healthy CAGR of 16.4%.

* Active Pharmaceutical Ingredients (APIs) Market in Asia Pacific to 2017 - Increasing Penetration in China and India Coupled with Low Cost Manufacturing to Fuel Regional Growth

This report presents detailed analysis and forecasts of the major economic and market trends affecting the API markets in the Asia-Pacific region.

This report was built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis conducted by GBI Research's team of industry experts.

Key Topics Covered:

1. List of Tables & Figures

2 Introduction

3 Contract Manufacturing Organizations (CMO)

4 Asia-Pacific Active Pharmaceutical Ingredients Market

5 Japan Active Pharmaceutical Ingredients Market

6 China Active Pharmaceutical Ingredients Market

7 South Korea Active Pharmaceutical Ingredients Market

8 India Active Pharmaceutical Ingredients Market

9 Appendix

For more information visit http://www.researchandmarkets.com/research/x9tc8t/active

[ InfoTech Spotlight's Homepage ]